SAN CLEMENTE, CA — Reflow Medical, Inc. announces that the Medical University of Graz has enrolled the first patient in the DEEPER CHALLENGE clinical trial. This investigator-initiated, single-center, single-arm, prospective study, supported...
SAN CLEMENTE, CA — Reflow Medical, Inc. announces that the Medical University of Graz has enrolled the first patient in the DEEPER CHALLENGE clinical trial. This investigator-initiated, single-center, single-arm, prospective study, supported...
“Healthcare is increasingly moving beyond the traditional hospital setting, and this acquisition positions us to lead that transformation,” said Eduardo Conrado, President and Chief Executive Officer of Ascension.
“Healthcare is increasingly moving beyond the traditional hospital setting, and this acquisition positions us to lead that transformation,” said Eduardo Conrado, President and Chief Executive Officer of Ascension.
The RED 72 SILVER LABEL devices are reperfusion catheters designed for acute ischemic stroke. Direct aspiration with RED 72 SILVER LABEL can provide a fast, frontline option for acute ischemic stroke. The COMPASS Trial has shown...
The RED 72 SILVER LABEL devices are reperfusion catheters designed for acute ischemic stroke. Direct aspiration with RED 72 SILVER LABEL can provide a fast, frontline option for acute ischemic stroke. The COMPASS Trial has shown...
This technique is expected to function as a simple, low-burden screening tool to help determine whether cardiac MRI is necessary in patients whose PR severity cannot be reliably assessed using echocardiography.
This technique is expected to function as a simple, low-burden screening tool to help determine whether cardiac MRI is necessary in patients whose PR severity cannot be reliably assessed using echocardiography.
Edwards Lifesciences announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which reinforce the company's leadership in advancing high-quality scientific evidence and...
Edwards Lifesciences announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which reinforce the company's leadership in advancing high-quality scientific evidence and...
The procedure, performed on June 15 by Annapoorna S. Kini, MD, MRCP, FACC, at Mount Sinai Fuster Heart Hospital in New York, represents a significant milestone in advancing intravascular imaging in the United States.
The procedure, performed on June 15 by Annapoorna S. Kini, MD, MRCP, FACC, at Mount Sinai Fuster Heart Hospital in New York, represents a significant milestone in advancing intravascular imaging in the United States.
“This early feasibility study for J-Valve is encouraging," said Dean J. Kereiakes, MD, MSCAI. "It shows that a dedicated device designed for aortic regurgitation can achieve sustained valve performance, meaningful symptom improvement, and...
“This early feasibility study for J-Valve is encouraging," said Dean J. Kereiakes, MD, MSCAI. "It shows that a dedicated device designed for aortic regurgitation can achieve sustained valve performance, meaningful symptom improvement, and...
A pacemaker without a box under the skin. Without wires to the heart. And without a battery that needs to be replaced every 7-10 years. It sounds like something from the distant future, but Dutch researchers at biotech company PacingCure have...
A pacemaker without a box under the skin. Without wires to the heart. And without a battery that needs to be replaced every 7-10 years. It sounds like something from the distant future, but Dutch researchers at biotech company PacingCure have...
The U.S. IDE study program will evaluate the purpose-built Shockwave™ SkyRunner Carotid IVL System designed to address the challenges of calcification in carotid arteries prior to stenting.
The U.S. IDE study program will evaluate the purpose-built Shockwave™ SkyRunner Carotid IVL System designed to address the challenges of calcification in carotid arteries prior to stenting.